Literature DB >> 22251080

Influence of formulation parameters on dissolution rate enhancement of glyburide using liquisolid technique.

Sachin Kumar Singh1, K K Srinivasan, K Gowthamarajan, Dev Prakash, Narayan B Gaikwad, Dhananjay S Singare.   

Abstract

The aim of this study was to investigate the use of liquisolid technique in improving the dissolution of glyburide in a solid dosage form. This study was designed to evaluate the effects of different formulation variables, i.e. type of non-volatile liquid vehicles and drug concentrations, on drug dissolution rates. The liquisolid tablets were formulated with Propylene glycol, as liquid vehicle. Microcrystalline cellulose was used as a carrier material, silica as a coating material and croscaremellose as a disintegrant. In vitro drug dissolution profiles of the liquisolid formulations were studied and compared with direct compressed non-micronized and micronized tablets of glyburide using USP II, paddle apparatus at 50 rpm for 60 min using 900 ml of 0.05 M Phosphate Buffer, pH 7.5. The stability studies showed that the dissolution profiles of liquisolid tablets prepared with propylene glycol were not affected by ageing significantly, as f2 value found between aged and fresh samples was 51.92. Differential scanning calorimetry revealed that the drug has got solubilized in the liquid vehicle. This was further supported by the powder X-ray diffraction studies of pure drug and the liquisolid powder system. It can be concluded that it is possible to load poorly soluble drug into liquisolid tablets by addition of PVP to the liquid vehicle. This is valuable for the preparation of liquisolid tablets of poorly soluble drugs. The liquisolid tablets prepared with PVP showed a remarkably improved dissolution rate in comparison with DC tablet and other formulations.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22251080     DOI: 10.3109/03639045.2011.634810

Source DB:  PubMed          Journal:  Drug Dev Ind Pharm        ISSN: 0363-9045            Impact factor:   3.225


  7 in total

1.  Application of liquisolid technology for enhancing solubility and dissolution of rosuvastatin.

Authors:  Pavan Ram Kamble; Karimunnisa Sameer Shaikh; Pravin Digambar Chaudhari
Journal:  Adv Pharm Bull       Date:  2013-12-24

2.  Novel biorelevant dissolution medium as a prognostic tool for polysaccharide-based colon-targeted drug delivery system.

Authors:  Ankit Kumar Yadav; Manik Sadora; Sachin Kumar Singh; Monica Gulati; Peddi Maharshi; Abhinav Sharma; Bimlesh Kumar; Harish Rathee; Deepak Ghai; Adil Hussain Malik; Varun Garg; K Gowthamrajan
Journal:  J Adv Pharm Technol Res       Date:  2017 Oct-Dec

3.  Liquigroud technique: a new concept for enhancing dissolution rate of glibenclamide by combination of liquisolid and co-grinding technologies.

Authors:  Leila Azharshekoufeh; Javad Shokri; Mohammad Barzegar-Jalali; Yousef Javadzadeh
Journal:  Bioimpacts       Date:  2017-02-28

4.  Liquisolid pellets: A pharmaceutical technology strategy to improve the dissolution rate of ritonavir.

Authors:  Brenda De Espíndola; André O'Reilly Beringhs; Diva Sonaglio; Hellen Karine Stulzer; Marcos Antônio Segatto Silva; Humberto Gomes Ferraz; Bianca Ramos Pezzini
Journal:  Saudi Pharm J       Date:  2019-04-03       Impact factor: 4.330

Review 5.  Liquisolid technique and its applications in pharmaceutics.

Authors:  Mei Lu; Haonan Xing; Jingzheng Jiang; Xiao Chen; Tianzhi Yang; Dongkai Wang; Pingtian Ding
Journal:  Asian J Pharm Sci       Date:  2016-11-04       Impact factor: 6.598

6.  Clinical Pharmacokinetic Evaluation of Optimized Liquisolid Tablets as a Potential Therapy for Male Sexual Dysfunction.

Authors:  Fayez O Alotaibi; Nabil A Alhakamy; Abdelsattar M Omar; Khalid M El-Say
Journal:  Pharmaceutics       Date:  2020-12-07       Impact factor: 6.321

7.  Evaluation of the effect of carrier material on modification of release characteristics of poor water soluble drug from liquisolid compacts.

Authors:  Beenish Ali; Amjad Khan; Hamad S Alyami; Majeed Ullah; Abdul Wahab; Munair Badshah; Attiqa Naz
Journal:  PLoS One       Date:  2021-08-02       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.